Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 5Colorectal Neoplasms 3Brain Neoplasms 3Rectal Neoplasms 2Neurotoxicity Syndromes 2Mesothelioma 2Colonic Neoplasms 2Agnosia 2Upper Abdominal Cancer Surgery 1Thyroid Neoplasms 1Stomach Neoplasms 1Seizures 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Pain, Postoperative 1Pain 1Paclitaxel-induced Neuropathy 1Neoplasms 1Myoma 1Leukemia, Myeloid, Acute 1Colorectal Cancer Screening 1Anesthesia 1

Interventions

Surveys and Questionnaires 114Exercise 103Blood Specimen Collection 99Radiotherapy 67Gemcitabine 64Bevacizumab 57Standard of Care 56Cisplatin 55Cyclophosphamide 51Capecitabine 50Carboplatin 49Docetaxel 47pembrolizumab 46Dexamethasone 46Paclitaxel 45Interviews as Topic 43Oxaliplatin 40Magnetic Resonance Spectroscopy 39Fluorouracil 37Methods 36Irinotecan 36Therapeutics 33Drug Therapy 33Radiosurgery 31Nivolumab 30Erlotinib Hydrochloride 27Educational Status 26Everolimus 24Leucovorin 23Control Groups 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms × Magnesium Sulfate × Clear all
NCT05663801 2024-12-27

Magnesium Sulphate Versus Ketamine as an Adjuvant to Bupivacaine in Pectoral Nerve Block During Mastectomy

Beni-Suef University

Phase 2 Completed
72 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡